ICAD Inc ICAD:NASDAQ

Last Price$5.38NASDAQ Closing Price as of 4:00PM ET 1/28/22

Today's Change+0.38(7.60%)
Bid (Size)$5.36 (2)
Ask (Size)$5.38 (3)
Day Low / High$4.89 - 5.39
Volume283.1 K
 

View Packaged Software IndustryPeer Comparison as of 01/28/2022

 

ICAD Inc ( NASDAQ )

Price: $5.38
Change: +0.38 (7.60%)
Volume: 283.1 K
4:00PM ET 1/28/2022
 
 

Brainstorm Cell Therapeutics Inc ( NASDAQ )

Price: $3.07
Change: +0.13 (4.42%)
Volume: 85.7 K
4:00PM ET 1/28/2022
 
 

Immersion Corp ( NASDAQ )

Price: $4.89
Change: +0.11 (2.30%)
Volume: 380.9 K
4:00PM ET 1/28/2022
 
 

AstroNova Inc ( NASDAQ )

Price: $13.22
Change: +0.52 (4.09%)
Volume: 5.4 K
4:00PM ET 1/28/2022
 
 

Iteris Inc ( NASDAQ )

Price: $3.84
Change: +0.05 (1.32%)
Volume: 333.5 K
4:00PM ET 1/28/2022
 

Read more news Recent News

Guggenheim Downgrades ICAD to Neutral From Buy
7:49AM ET 1/18/2022 MT Newswires

ICAD (ICAD) has an average rating of buy and price targets ranging from $13 to $25, according to analysts polled by Capital IQ. (MT Newswires covers...

Insider Sell: Icad
12:44PM ET 1/11/2022 MT Newswires

Andy Sassine, Director, on January 06, 2022, sold 20,000 shares in Icad (ICAD) for $122,700. Following the Form 4 filing with the SEC, Sassine has control...

Insider Buy: Icad
11:00AM ET 1/06/2022 MT Newswires

Stacey M Stevens, President, on January 05, 2022, executed a purchase for 17,006 shares in Icad (ICAD) for $104,927. Following the Form 4 filing with the...

Oppenheimer Adjusts icad PT to $16 From $22, Maintains Outperform Rating
10:26AM ET 1/05/2022 MT Newswires

Oppenheimer lowered its price target on icad (ICAD) to $16 from $22 following the company's reported Q4 miss, which resulted in a loss of more than 21% in...

Company Profile

Business DescriptioniCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment include image analysis and workflow products. The Cancer Therapy segment consists radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH. View company web site for more details
Address98 Spit Brook Road
Nashua, New Hampshire 03062
Phone+1.603.882.5200
Number of Employees97
Recent SEC Filing01/26/20224
Executive Chairman & Chief Executive OfficerMichael S. Klein
President & DirectorStacey M. Stevens
Chief Financial Officer & SecretaryCharles R. Carter
Chief Technology OfficerJonathan Go

Company Highlights

Price Open$5.09
Previous Close$5.00
52 Week Range$4.06 - 21.44
Market Capitalization$135.1 M
Shares Outstanding25.1 M
SectorTechnology Services
IndustryPackaged Software
Next Earnings Announcement02/23/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.35
Beta vs. S&P 500N/A
Revenue$25.6 M
Net Profit Margin-23.98%
Return on Equity-18.84%

Analyst Ratings as of 01/14/2022

Buy
6
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset